Global Patent Index - EP 1015610 A2

EP 1015610 A2 20000705 - MEDICAMENT FOR TREATING A MANIFESTED LYME DISEASE

Title (en)

MEDICAMENT FOR TREATING A MANIFESTED LYME DISEASE

Title (de)

ARZNEIMITTEL ZUR THERAPIE EINER MANIFESTEN LYME-BORRELIOSE

Title (fr)

MEDICAMENT POUR LE TRAITEMENT D'UNE BORRELIOSE DE LYME MANIFESTE

Publication

EP 1015610 A2 20000705 (DE)

Application

EP 98946455 A 19980915

Priority

  • DE 19740735 A 19970916
  • EP 9805852 W 19980915

Abstract (en)

[origin: DE19740735A1] Polyclonal and monoclonal antibodies specific for the Borrelia burgdorferi 24 kD antigen OspC are new. Independent claims are also included for the following: (1) an antigen that immunoreacts with an antibody as above; (2) recombinant DNA encoding the antigen; and (3) a recombinant vector containing at least one copy of the DNA.

IPC 1-7

C12N 15/63; C12N 15/31; A61K 39/40; C07K 16/12; C07K 14/195

IPC 8 full level

C07K 14/20 (2006.01); C07K 16/12 (2006.01); C12N 15/31 (2006.01); A61K 38/00 (2006.01); A61K 39/00 (2006.01)

CPC (source: EP US)

C07K 14/20 (2013.01 - EP US); C07K 16/1207 (2013.01 - EP US); A61K 38/00 (2013.01 - EP US); A61K 39/00 (2013.01 - EP US); C07K 2319/00 (2013.01 - EP US); Y02A 50/30 (2018.01 - EP US)

Designated contracting state (EPC)

AT BE CH DE DK ES FI FR GB GR IE IT LI NL PT SE

DOCDB simple family (publication)

DE 19740735 A1 19990318; AU 9348598 A 19990405; EP 1015610 A2 20000705; US 6761891 B1 20040713; WO 9914345 A2 19990325; WO 9914345 A3 19990514

DOCDB simple family (application)

DE 19740735 A 19970916; AU 9348598 A 19980915; EP 9805852 W 19980915; EP 98946455 A 19980915; US 50809600 A 20000706